HomeNewsMedical Cannabis Benefits Survey Results

Medical Cannabis Benefits Survey Results

Another study has indicated patients experiencing benefits from cannabis use for a variety of conditions where conventional treatments proved ineffective or unacceptable.

Founded in 2013, Realm of Caring (RoC) is a registered charity providing information about cannabinoid therapies. A large online study conducted by RoC and researchers at the Johns Hopkins University School of Medicine found medical cannabis helped alleviate the impacts of various neurological disorders and pain-related ailments.

Involving 808 respondents, the research indicates 77% of participants reported positive effects. More specifically, 28% cited a reduction in pain, 18% improved sleep and 22% reduced anxiety.  Additionally, 12% reported reduced use of other medications such as opioids. Mental health improvements were reported by 29% of respondents.

Reasons for turning to cannabis included traditional treatments being ineffective and/or intolerable (51%), motivation from positive scientific or media portrayals (29%) and a preference for natural products (21%) . 17% indicated cannabis was being used as a “last resort”, or use was primarily driven by curiosity or other factors.

17% said they initiated medicinal cannabis use after a recommendation by a healthcare provider or other trusted individual, such as a family member.

Participants also identified issues and challenges faced in using medical cannabis; including locating sufficiently educated health providers and information on the most effective consumption methods. A lack of information on medical cannabis support was cited by 16% of participants and 12% reported costs as a concern.16% also noted unwanted side effects.

The most used medical cannabis products by participants were cannabidiol (CBD) dominant (58%), primarily for the treatment/management of neurological disorders (38%) or pain (25%).

“This research spotlights several concerns that we actively address, such as providing information to the medical community, partnering with quality product companies for more affordable options, and providing free one-on-one support to alleviate unwanted side effects,” said  RoC Executive Director Sasha Kalcheff-Korn.

The conclusion states data indicate greater research and education on the safety and efficacy of medicinal cannabis/cannabinoid use is warranted – a common theme in many related studies.

The full study, which has been published in the journal Frontiers in Pharmacology, can be accessed here.

Terry Lassitenaz
Terry Lassitenaz writes exclusively for Hemp Gazette and has done so since the site launched in 2015. He has a special interest in the political arena relating to medical cannabis, particularly in Australia, and addressing the many myths surrounding this incredibly useful plant. You can contact Terry here.

Most Popular